Pre-Annual General Meeting Information • Apr 15, 2024
Pre-Annual General Meeting Information
Open in ViewerOpens in native device viewer
If you are in any doubt as to any aspect of the proposals referred to in this document or as to the action you should take, it is recommended that you seek your own advice from a stockbroker, solicitor, accountant or other independent professional adviser authorised under the Financial Services and Markets Act 2000 if you are resident in the United Kingdom, or, if you reside elsewhere, another appropriately authorised financial adviser.
If you have sold or otherwise transferred all of your shares, please pass this document together with the accompanying documents with the exception of the personalised Form of Proxy to the purchaser or transferee, or to the person who arranged the sale or transfer so they can pass these documents to the person who now holds the shares.
Notice of Annual General Meeting 2024 to be held on Thursday, 16 May 2024, 12:00 noon at the offices of Linklaters LLP, One Silk Street, London EC2Y 8HQ.
VISTRY GROUP PLC 11 Tower View Kings Hill West Malling Kent ME19 4UY
Company no. 00306718
"I am pleased to enclose the Notice of Annual General Meeting 2024 for Vistry Group PLC (the Company), which will be held on Thursday, 16 May 2024, 12:00 noon at the offices of Linklaters LLP, One Silk Street, London EC2Y 8HQ."
RALPH FINDLAY OBE Chair
The Notice of Meeting (Notice) is set out on pages 3 to 5 with the explanatory notes on pages 6 to 13.
The Company's 2024 Annual General Meeting (the AGM) is a key event in the Company's corporate calendar as it provides an important occasion for the Company to engage with its shareholders and I hope you take the opportunity to come along and participate. Shareholders who choose to attend the AGM in person, should preregister their intention to attend as soon as practicable by emailing [email protected] and by no later than 5.00pm on 15 May 2024.
Shareholders may submit questions to the Board in advance of the AGM by email to investor.relations@vistry. co.uk or by post to the Group Company Secretary at 11 Tower View, Kings Hill, West Malling, Kent, ME19 4UY. Please submit questions by 5.00pm on 15 May 2024. We will consider all questions received and provide a response during the AGM. Responses to questions will also be provided on our website www.vistrygroup.co.uk/investor-centre.
The Annual Report and Accounts for the year ended 31 December 2023 is available on the Company's website www.vistrygroup.co.uk/investor-centre/annualreport-2023. For shareholders who have elected for hard copy communications, a copy of the Annual Report and Accounts and Form of Proxy is enclosed with this Notice.

Shareholders who are able to attend the AGM on the day will be able to cast their vote at the AGM in person using the poll cards provided. Those shareholders who are unable to attend will be able to register their proxy vote in advance of the meeting, either online or through the return of the completed paper Form of Proxy. Further information on voting at the AGM is detailed on page 11 of this Notice.
There were a number of Board changes during the year. On 23 March 2023, Jeffrey Ubben was appointed as a Non-Executive Director and Nigel Keen stepped down as an Independent Non-Executive Director. Ashley Steel and Katherine Innes Ker both stepped down as Independent Non-Executive Directors on 18 May 2023, from the conclusion of the 2023 Annual General Meeting. Helen Owers and Paul Whetsell were both appointed as Independent Non-Executive Directors on 18 May 2023 with Paul also appointed as Chair of the Remuneration Committee.
On 12 January 2024, it was announced that Jeffrey Ubben had stepped down as a Non-Executive Director and Usman Nabi was appointed to the Board as a Non-Executive Director, representing our largest shareholder Browning West. The Company has entered into an agreement with Browning West which clarifies the obligations of, and relationship between, both parties in respect of Usman's appointment.
It was also announced on 12 January 2024 that I shall step down as Chair with effect from the conclusion of the AGM. I was appointed to the Board in April 2015 and as such, my nine-year tenure shall be completed shortly before I step down. Greg Fitzgerald shall succeed me as Executive Chair and CEO. Greg will ensure consistency and continuity in the execution of the revised strategy, utilising his 40 years of experience and value creation in the sector, including a successful period in a similar role as Executive Chair of Galliford Try. Greg's appointment, supported by a strong Senior Independent Director, will allow for a smooth handover without disruption to the business and ensures Greg's commitment to oversee the delivery of our medium-term targets. I am therefore pleased to announce that Rob Woodward will join the Board as Senior Independent Director with effect from the close of the AGM. Rob will have an enhanced role providing additional oversight on governance matters, as well as a high level of engagement with investors and other stakeholders. Further, Rob will become Chair of the Nomination Committee, leading on the recruitment of new Non-Executive Directors and, in conjunction with the Executive Chair and CEO, oversee the succession planning of executive management. Alice Woodwark will also join the Board with effect from the close of the AGM as an Independent Non-Executive Director. Both Rob and Alice will be standing for election at the forthcoming AGM. We are delighted to have recruited two new high calibre Directors to the Board, in particular putting in place a strong Senior Independent Director to bolster our Board governance. Rob and Alice's respective experience in both the public and private sectors will be hugely valuable as we continue to execute the Group's Partnership strategy.
I am also pleased to announce that Chris Browne has agreed to remain on the board as a Independent Non-Executive Director for up to one more year to ensure continuity and allow the Board more time to recruit a further Independent Non-Executive Director. She will therefore be seeking re-election at the AGM.
I would like to thank all of the Directors who left the Board in 2023 for their contributions during a period of transformation of the Company.
On 11 September 2023, we announced the Group's half year results and strategy update which included further detail on the Board's intention to pursue two times adjusted earnings ordinary distribution cover in respect of the full financial year, with such distributions made through either dividends or share buybacks.
On 11 December 2023, the Company commenced a £55 million share buyback programme (the Programme) which concluded on 23 February 2024. As part of the Programme, the Company purchased 5,759,041 shares, of which 5,509,041 were cancelled and 250,000 placed into treasury. The Company operated the Programme as a way to return value to shareholders by reducing the Company's share capital.
In line with the Group's capital allocation policy the Board has announced a further ordinary share buyback programme of approximately £100m which is expected to commence in April.
Your Directors are of the opinion that all of the resolutions to be put to the meeting are likely to promote the success of the Company and are in the best interests of the Company and its shareholders as a whole. Your Directors unanimously recommend that you vote in favour of the resolutions as they will be doing in respect of their own beneficial shareholdings.
Yours faithfully,
NOTICE IS HEREBY GIVEN that the 2024 Annual General Meeting of Vistry Group PLC (Company) will be held on Thursday, 16 May 2024, 12:00 noon at the offices of Linklaters LLP, One Silk Street, London, EC2Y 8HQ.
For the purposes of this resolution, the terms "political donation", "political parties", "independent election candidates", "political organisation" and "political expenditure" have the meanings given by sections 363 to 365 of the 2006 Act.
That the Directors be generally and unconditionally authorised to allot shares in the Company and to grant rights to subscribe for or to convert any security into shares in the Company pursuant to and in accordance with section 551 of the 2006 Act:
(a) up to an aggregate nominal amount of £56,740,016; and
such authorities to apply (unless previously renewed, varied or revoked by the Company in a general meeting), in substitution for all previous authorities pursuant to section 551 of the 2006 Act, until the conclusion of the next Annual General Meeting after the passing of this resolution, or, if earlier, 15 months after the date on which this resolution is passed, but in each case so that the Company may, before such period ends, make offers and enter into agreements which would, or might, require shares to be allotted, or rights to subscribe for or convert any security into shares to be granted, after such period ends and the Directors may allot shares and grant rights under any such offer or agreement as if such period had not ended.
such authorities to apply (unless previously renewed, varied or revoked by the Company in a general meeting) until the conclusion of the next Annual General Meeting of the Company after the passing of this resolution, or, if earlier, 15 months after the date on which this resolution is passed, but in each case so that the Company may, before such period ends, make offers and enter into agreements which would, or might, require shares to be allotted, or rights to subscribe for or convert any security into shares to be granted, after such period ends and the Directors may allot shares and grant rights under any such offer or agreement as if such period had not ended.
such authority to apply (unless previously renewed, varied or revoked by the Company in a general meeting) until the conclusion of the next Annual General Meeting of the Company after the passing of this resolution or, if earlier, 15 months after the date on which this resolution is passed, but in each case so that the Company may before such period ends, make offers and enter into agreements during the relevant period which would, or might, require shares to be allotted, or rights to subscribe for or convert any security into shares to be granted, after such period ends and the Directors may allot shares and grant rights under any such offer or agreement as if such period had not ended.
For the purposes of this resolution references to an allotment of equity securities shall include a sale of treasury shares.
By Order of the Board
General Counsel and Group Company Secretary
4 April 2024
Resolutions 1 to 16 (inclusive) will be proposed as ordinary resolutions. For each of these Resolutions to be passed, more than half of the votes cast must be in favour of the Resolution.
Resolutions 17 to 20 (inclusive) will be proposed as special resolutions. For each of these Resolutions to be passed, at least three quarters of the votes cast must be in favour of the Resolution
The Directors are required to present to shareholders at the Annual General Meeting the report of the Directors, the Strategic report and the accounts of the Company for the year ended 31 December 2023. The report of the Directors, the Strategic report, the accounts, the report of the Company's auditors on the accounts and those parts of the Directors' Remuneration report that are capable of being audited are contained in the Company's annual report and accounts for the year ended 31 December 2023 (the "Annual Report 2023") which can be found at www.vistrygroup.co.uk/investorcentre/annual-report-2023.
Under section 439 of the Companies 2006 Act, the Directors are required to present the Directors' Remuneration report prepared, in accordance with Schedule 8 of the Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008 (as amended), for the approval of shareholders by way of an advisory vote. The Directors' Remuneration report, which can be found on pages 115 to 131 of the Annual Report 2023, gives details of the Directors' remuneration for the year ended 31 December 2023 and sets out the way in which the Company has implemented the Remuneration Policy approved by shareholders at the General Meeting in August 2023 and how it will implement its policy on Directors' remuneration during 2024. The Company's auditors, PricewaterhouseCoopers LLP, have audited those parts of the Directors' Remuneration report capable of being audited and their report may be found on pages 146 to 157 of the Annual Report 2023.
The vote on the Directors' Remuneration report is advisory in nature in that payments made or promised to Directors will not have to be repaid, reduced or withheld in the event that this resolution is not passed. However, if the vote on the Directors' Remuneration report is not passed, the Directors' Remuneration Policy will be presented to shareholders for approval at the next Annual General Meeting.
In accordance with the recommendations of the UK Corporate Governance Code 2018 (the 'Code') and the requirements of the Company's Articles of Association, all directors retire at the AGM and those wishing to serve again offer themselves for re-election.
Helen Owers and Paul Whetsell were appointed to the Board on 18 May 2023 following the 2023 Annual General Meeting and will therefore be standing for election at the AGM. Usman Nabi was appointed to the Board on 12 January 2024 and will also be standing for election. Rob Woodward and Alice Woodwark will join the Board from the close of the AGM and each will be also be standing for election at the AGM. Chris Browne will stand for re-election for up to one more year to ensure continuity and allow the Board more time to recruit a further Independent Non-Executive Director. All the remaining Directors (with the exception of Ralph Findlay) will be submitting themselves for re-election by shareholders.
The Board has carefully considered whether each of the Non-Executive Director is free from any relationship that could materially interfere with the exercise of their independent judgement. It has concluded that each Non-Executive Director is independent (with the exception of Usman Nabi who is a representative of Browning West, the Company's largest shareholder). The Board has also reviewed and concluded that each Non-Executive Director possesses the necessary mix of skills and experience to continue to contribute effectively to the company's long-term sustainable success. The Board believes that the Directors' combined experience and contribution is a great asset to the Board and the Company and continues to be important to the Company's long-term sustainable success. The Board, therefore, strongly supports and recommends the appointment and re-appointment (as applicable) of the Directors to shareholders.
Biographical details of all the Directors standing for election and re-election (other than Rob Woodward and Alice Woodwark) can be found on pages 76 and 77 of the Annual Report 2023. The biography for Rob Woodward and Alice Woodwark are set out on the next page.
Rob has held leadership positions across both the public and private sectors. He has been Chair of the Met Office since 2018, a role he will relinquish later this year after two terms. His experience includes over 10 years as Chief Executive Officer of STV Group plc leading its successful transformation into a pre-eminent digital media group. He had previously been Commercial Director at Channel 4 Television, Managing Director with UBS Corporate Finance and lead partner for Deloitte's Telecoms, Media & Technology Industry Group in Europe.
Rob is also currently Chair of Court at Glasgow Caledonian University and Chair of listed marketing analytics provider, Ebiquity plc. Until it's recent delisting he was Chair of technology company Blancco plc.
In his position as Senior Independent Director, Rob will have an enhanced role providing additional oversight on governance matters, as well as a high level of engagement with investors and other stakeholders. Further, Rob will become Chair of the Nomination Committee, leading on the recruitment of new Non-Executive Directors and, in conjunction with the Executive Chair and CEO, oversee the succession planning of executive management. He will also serve on the Audit Committee and Remuneration Committee.
Alice has been Managing Director of Mitie Group plc's Communities division since 2021. She started her career with management consultancy McKinsey, working extensively across the UK and US in the infrastructure, transport, hospitality and retail sectors. Alice joined Compass Group in 2013, serving as Group Head of Strategy and M&A and subsequently in Managing Director positions for Compass UK. Alice will serve from appointment as a member of the Nomination Committee, Remuneration Committee and Audit Committee.
| ROWAN BAKER INDEPENDENT NON-EXECUTIVE DIRECTOR |
• Highly experienced CFO at Laing O'Rourke PLC which is in the construction and development sector. |
|---|---|
| • Extensive experience of the construction industry and the challenges it faces to improve productivity, deliver greater certainty for clients and overcome a long-standing skills shortage. |
|
| • Chair of the Audit Committee. | |
| CHRIS BROWNE INDEPENDENT NON-EXECUTIVE DIRECTOR |
• Strong consumer focused background with extensive operational and leadership skills. These skills align with key areas of the Group's strategy and keen focus on customer service, quality and people. |
| • Provides continuity, with extensive knowledge of the Group having served on the Board for over 9 years. |
|
| HELEN OWERS INDEPENDENT NON-EXECUTIVE DIRECTOR |
• Served as a Non-Executive Director of Informa plc, a FTSE 100 listed company. |
| • Operational and Non-Executive Director experience, serving on a number of remuneration committees including as Chair. |
|
| • Designated employee engagement Non-Executive Director. | |
| • Expertise in sustainability and Non-Executive Director representative on the Sustainability Committee. |
|
| PAUL WHETSELL INDEPENDENT NON-EXECUTIVE DIRECTOR |
• Experienced CEO and Non-Executive Director serving on boards of listed companies with industry experience, having served on the board of a leading American homebuilder, NVR, Inc. |
| • Chair of the Remuneration Committee. | |
| USMAN NABI NON-EXECUTIVE DIRECTOR |
• Experienced Non-Executive Director with strong board and broad strategic advisory experience. |
| • Highly experienced investor in the US and UK. | |
| • Strong focus on increasing shareholder value. | |
Contributions and reasons for election/re-election are set out in the table below:
| ROB WOODWARD INDEPENDENT NON-EXECUTIVE DIRECTOR |
• Experienced CEO with executive and operational transformation experience within listed companies. |
|---|---|
| • Senior Independent Director and holds current Chair and Non-Executive Director roles in listed and Government agency organisations. |
|
| ALICE WOODWARK INDEPENDENT NON-EXECUTIVE DIRECTOR |
• Extensive experience within management consultancy across the UK and US as well as holding senior executive roles within FTSE companies. |
| • Strong focus on delivering strategic and operational change and investment in people driven culture. |
|
| GREG FITZGERALD EXECUTIVE DIRECTOR |
• Extensive operational and leadership experience within the construction industry. |
| • Delivering revised strategy focusing on Partnerships model. | |
| • Experience fufilling the dual role of Executive Chair and CEO at Galliford Try. | |
| TIM LAWLOR EXECUTIVE DIRECTOR |
• Leadership, strategic focus, extensive corporate and commercial experience, financial and accounting experience. |
| • Sets the financial strategy for the Group and covers all areas of finance. | |
| EARL SIBLEY EXECUTIVE DIRECTOR |
• Extensive sector-specific strategic and financial experience. |
| • Successfully oversaw the integration with Countryside and achievement of targeted synergies. |
The auditor of a company must be appointed at each general meeting at which accounts are presented. Resolution 13 proposes the re-appointment of the Company's existing auditor, PricewaterhouseCoopers LLP, as the Company's auditor for a further year. PricewaterhouseCoopers LLP were first appointed at the 2015 Annual General Meeting. Resolution 14 gives authority to the Audit Committee (on behalf of the Board of Directors) to determine the auditor's remuneration. Details on how the Audit Committee assessed the performance, effectiveness and independence of the auditor is detailed within the Audit Committee report found on pages 100 to 108 of the Annual Report 2023.
Part 14 of the 2006 Act requires companies to obtain shareholders' authority for donations to registered political parties and other political organisations totalling more than £5,000 in any twelve-month period, and for any political expenditure, subject to limited exceptions.
The definition of donation in this context is very wide and extends to bodies such as those concerned with policy review, law reform and the representation of the business community. It could include special interest groups, such as those involved with the environment, which the Company and its subsidiaries might wish to support, even though these activities are not designed to support or influence support for a particular party.
It remains the Group's policy not to make political donations or incur political expenditure as those expressions are normally understood. However, it is possible that certain routine activities undertaken by the Company and its subsidiaries might unintentionally fall within the wide definition of matters constituting political donations and expenditure in the 2006 Act. Any expenditure that is regulated under the 2006 Act must first be approved by shareholders and will be disclosed in next year's Annual Report. This resolution, if passed, will give the Directors authority to make political donations and incur political expenditure until the next Annual General Meeting of the Company (when the Directors intend to review this authority to make donations and incur expenditure which might otherwise be caught by the terms of the 2006 Act), up to an aggregate of £100,000.
There were no political donations made in 2023.
The authority given to your Directors at last year's Annual General Meeting under section 551 of the 2006 Act to allot shares expires on the date of the forthcoming Annual General Meeting. Accordingly, limb (a) of resolution 16 seeks to grant a new authority under section 551 to authorise the Directors to allot shares in the Company or grant rights to subscribe for, or convert any security into, shares in the Company up to an aggregate nominal amount of £56,740,016 and limb (b) of resolution 16 also gives the Board authority to allot, in addition to these shares, further of the Company's shares up to an aggregate nominal amount of £56,740,016 in connection with a pre-emptive offer to existing members in connection with a pre-emptive offer (with exclusions or other arrangements as the Directors may deem necessary or expedient in relation to treasury shares, fractional entitlements, record dates or legal, regulatory or practical problems in, or under the laws of, any territory). This is in accordance with the Investment Association's Share Capital Management Guidelines.
The amount of £56,740,016 in limb (a) of resolution 16 represents approximately 33% of the Company's total ordinary share capital in issue as at the close of business on 4 April 2024 (being the latest practicable date prior to publication of this Notice). The amount of £56,740,016 in limb (b) of resolution 16 represents approximately 33% of the Company's total ordinary share capital in issue as at the close of business on 4 April 2024 (being the latest practicable date prior to publication of this Notice). The aggregate of the amounts in paragraphs (a) and (b) of Resolution 16 therefore represents a total of approximately 66% of the whole of the issued ordinary share capital of the Company, exclusive of shares held in treasury, as at the close of business on 4 April 2024. The Company held 1,004,363 shares in treasury as at the close of business on 4 April 2024 which represents 0.29% of the total number of ordinary share in issue, excluding shares held in treasury, at that date.
The Board has no present intention to undertake a pre-emptive offer or to allot new shares other than in connection with employee share schemes. The Company currently operates an Employee Benefit Trust for the purpose of satisfying options and share awards (further details of which can be found on page 8 of this Notice); however the Directors regard it appropriate to ensure that the Company maintains the maximum flexibility as permitted by the Investment Association's Share Capital Management Guidelines and so that allotments can be made (should it be desirable and should suitable market conditions arise) at short notice and without the need to convene a general meeting of the Company which would be both costly and time consuming.
If the resolution is passed, the authority granted under resolution 16 will expire at the conclusion of the next Annual General Meeting after the passing of this resolution, or, if earlier, 15 months after the date on which this resolution is passed. The Directors intend to seek renewal of this authority at subsequent Annual General Meetings.
In 2023, the Company allotted 42,614 ordinary shares in connection with the exercise of option under the Company's employee share plans.
Under section 561(1) of the 2006 Act, if the Directors wish to allot ordinary shares, or grant rights to subscribe for, or convert securities into, ordinary shares (which for this purpose includes a sale of treasury shares for cash), other than pursuant to an employee share scheme, they must first offer them to existing shareholders in proportion to their holdings. There may be occasions, however, when the Directors need the flexibility to finance business opportunities by the issue of shares without a pre-emptive offer to existing shareholders. This cannot be done under the 2006 Act unless the shareholders have first waived their pre-emption rights. The purpose of these resolutions is to give the Board such flexibility, in line with the limits set by the guidance of the UK's Pre-Emption Group and supported by the Pensions and Lifetime Savings Association and by the Investment Association as representatives of share owners and investment managers.
Resolutions 17 and 18 are each proposed as special resolutions. Limb (a) of resolution 17 will, if passed, allow the Directors to allot a limited number of ordinary shares or other equity securities, or sell treasury shares, for cash on a pre-emptive basis but subject to such exclusions or arrangements as the Directors may deem appropriate to deal with certain legal, regulatory or practical difficulties. For example, in a pre-emptive rights issue, there may be difficulties in relation to fractional entitlements or the issue of new shares to certain shareholders, particularly those resident in certain overseas jurisdictions. Limb (b) of resolution 17 will, if passed, allow the Directors to allot new shares or other equity securities pursuant to resolution 16, or sell treasury shares, for cash without first being required to offer such shares to existing shareholders in proportion to their existing holdings up to an aggregate maximum nominal amount of £17,039,044 (which includes, for this purpose, the sale on a non-pre-emptive basis of any shares held in treasury).
This amount represents approximately 10% of the issued ordinary share capital of the Company, excluding shares held in treasury, and approximately 9.97% of the total issued share capital of the Company, including shares held in treasury, on 4 April 2024 (the latest practicable date prior to the publication of this Notice).
In addition, the Pre-Emption Group's Statement of Principles (as last updated in November 2022) support the annual disapplication of pre-emption rights in respect of allotments of shares and other equity securities and sales of treasury shares for cash where these represent no more than an additional 10% of issued ordinary share capital (exclusive shares held in treasury), and are used only in connection with an acquisition or specified capital investment. The Pre-Emption Group's Statement of Principles defines "specified capital investment" as meaning one or more specific capital investment related uses for the proceeds of an issue of equity securities, in respect of which sufficient information regarding the effect of the transaction on the Company, the assets the subject of the transaction and (where appropriate) the profits attributable to them is made available to shareholders to enable them to reach an assessment of the potential return. Accordingly, the purpose of limb (a) of Resolution 18 is to authorise the Directors to allot new shares and other equity securities, or sell treasury shares for cash, pursuant to the authority to allot granted by Resolution 16, only in connection with an acquisition or other capital investment which is announced contemporaneously with the allotment or which has taken place in the preceding twelve-month period and is disclosed in the announcement of the issue, up to a further maximum aggregate nominal amount of £17,039,044. This represents approximately 10% of the issued ordinary share capital of the Company, excluding shares held in treasury, and approximately 9.97% of the total issued share capital of the Company, including shares held in treasury, on 4 April 2024, (the latest practicable date prior to the publication of this Notice). The additional authority to allot up to approximately 10% of the issued ordinary share capital is sought for use in connection only with an acquisition or specified capital investment of a kind contemplated by the Pre-Emption Group's Statement of Principles on Disapplying Pre-Emption Rights and not for general corporate purposes.
Finally, the Statement of Principles referred to above also introduces the concept of "follow-on" offers to help existing and retail investors to participate in equity issues. This is in line with the recommendations for improving capital raising processes which were made by the UK Secondary Capital Raising Review in July 2022. The purpose of limb (c) of resolution 17 and limb (b) of resolution 18 is therefore to give the Directors the flexibility to make a follow-on offer. This wording has been drafted in accordance with the template resolutions published by the Pre-Emption Group in November 2022. The features of follow-on offers which are set out in the Statement of Principles (in Part 2B, paragraph 3) include an individual monetary cap of not more than £30,000 per ultimate beneficial owner, limits on the number of shares issued in any follow-on offer (not more than 20% of the number issued in the placing), and limits on the price (equal to, or less than, the offer price in the placing). The maximum amount which can be issued in a follow-on offer is £6,815,617. This amount is in addition to the amounts authorised for the general use authority and authority for acquisitions and specified capital investments described above, and, in total, is equivalent to 4% of the total issued ordinary share capital of the Company, excluding shares held in treasury, and 3.99% of the total issued ordinary share capital of the Company, including shares held in treasury, as at the close of business on 4 April 2024 (the latest practicable date prior to the publication of this Notice).
The Directors do not have any present intention of exercising the authorities under Resolutions 17 and 18 but consider the authorities appropriate to, as noted above, allow the Company the flexibility to finance business opportunities by the issue of shares without a pre- emptive offer to existing shareholders. Any such issuance would occur in prior consultation with the relevant investor groups.
The Board confirms that, it intends to follow the shareholder protections set out in Section 2B of the Pre-Emption Group's Statement of Principles and, for any follow-on offer made, the expected features set out in paragraph 3 of Section 2B of the Pre-Emption Group's Statement of Principles.
The Directors believe that the authorities sought in these Resolutions are in the best interests of the Company and note that they comply with the IA guidelines and the Pre-Emption Group's Statement of Principles.
If the resolutions are passed, the authorities granted under resolutions 17 and 18 will expire at the conclusion of the next Annual General Meeting of the Company or, if earlier, 15 months after the date on which this resolution is passed.
The Company did not utilise the authority granted under this resolution in 2023.
This resolution is required as a result of the implementation in 2009 of the Shareholder Rights Directive. The regulation implementing this Directive increased the notice period for general meetings under the 2006 Act to 21 days. The Company will be able to continue to call general meetings (other than an Annual General Meeting) on 14 clear days' notice as long as shareholders have approved the calling of meetings on 14 days' notice. Resolution 16 seeks such approval. The approval will be effective until the Company's next Annual General Meeting, where it is intended that a similar resolution will be proposed. The Company will also need to meet the requirements for electronic voting under the Directive before it can call a general meeting on 14 days' notice. It is confirmed that the ability to call a general meeting on 14 clear days' notice would only be utilised in limited circumstances and where the shorter notice period will be to the advantage of shareholders as a whole.
In this resolution, shareholders are being asked to grant the Board authority to buy the Company's own shares, subject to the constraints set out in resolution 20.
The Directors recognise the importance of capital distributions to shareholders. Any surplus capital following investment in the business to support the Partnership's growth strategy and the ordinary distribution is expected to be returned to the Group's shareholders through either an incremental share buyback or a special dividend, with the method being determined by the Board considering all relevant factors at the time.
The Board utilised the authority granted at the 2023 AGM to purchase own shares during 2023 and into early 2024 to return capital to its shareholders of approximately £90 million through buying back 5,759,041 shares, of which 250,000 were held in treasury and remaining 5,509,041 were cancelled. In line with the Group's capital allocation policy the Board has announced a further ordinary share buyback programme of approximately £100m which is expected to commence in April, pursuant to the authority granted at the 2023 annual general meeting. To support the Group's target of a £1bn capital distribution to its shareholders through to and including financial year 2026, the Board proposes to increase the current 10% authority approved by shareholders at the 2023 annual general meeting to 14.99% of the Company's total ordinary share capital (excluding treasury shares). This is intended to provide the Board with additional flexibility to manage the Company's share capital and make returns to shareholders and this authority would allow the Company to deliver distributions to shareholders through further share buybacks in line with the Group's capital allocation policy. The Directors will exercise the authority to make market purchases of the Company's own shares only when to do so would be in the best interest of the Company and promote the success of the Company for the benefit of its shareholders as a whole, and would lead to an increase in the Company's earnings per share. The Board will evaluate additional special distributions throughout the year.
This resolution therefore authorises the Company to make market purchases of up to 51,083,054 of its own shares, representing approximately 14.99% of the Company's total ordinary share capital (excluding treasury shares) in issue as at 4 April 2024 (being the latest practicable date prior to publication of this Notice). Before exercising such authority, the Directors would ensure that the Company was complying with the current relevant UK Listing Authority rules and Investment Association guidelines.
Any shares purchased would be cancelled or purchased into treasury which the Company can re-issue quickly and cost effectively providing the Company with additional flexibility in the management of its capital base. As at 4 April 2024, the Company held 1,004,363 shares in treasury. The Company does not intend to hold more than 10% of its shares in treasury in accordance with the IA Share Capital Management guidelines. Any purchases of ordinary shares would be by means of market purchases through the London Stock Exchange, subject to minimum and maximum price limits which may be paid for any shares purchased under this authority, which reflect the requirements of the Listing Rules. The authority will only be valid until the conclusion of the next Annual General Meeting in 2025.
The Company operates an Employee Benefit Trust (the "EBT") which holds shares for the purpose of satisfying options or share awards issued pursuant to the Company's employee share schemes. At present, awards issued pursuant to the employee share schemes are satisfied through the EBT or by transferring shares out of treasury; however the Directors reserve their position, and may elect to repurchase shares. As at 31 December 2023, 430,025 shares were held in the EBT.
As at 4 April 2024 there were options over 2,059,618 ordinary shares in the capital of the Company which represent 0.60% of the Company's issued ordinary share capital at that date. If the authority to purchase the Company's ordinary shares was exercised in full, these options would represent 0.71% of the Company's issued ordinary share capital.
The Directors consider that all the resolutions to be put to the meeting promote the success of the Company for the benefit of its shareholders as a whole. Your Board will be voting in favour of them and unanimously recommends that you do so as well.
(iii) Voting on all substantive resolutions will be by way of a poll. When announcing the results of the poll vote, the Company will disclose the total number of votes in favour and against as well as the number of abstentions on the Company website (vistrygroup. co.uk) and through a RIS announcement. If a member returns both paper and electronic proxy instructions, those received last by the Registrar before the latest time for receipt of proxies will take precedence. Members are advised to read the website terms and conditions of use carefully.
(x) If you are an institutional investor you may be able to appoint a proxy electronically via the Proxymity platform, a process which has been agreed by the Company and approved by the Registrar. For further information regarding Proxymity, please go to www.proxymity.io. Your proxy must be lodged by 11:00am on 14 May 2024 in order to be considered valid. Before you can appoint a proxy via this process you will need to have agreed to Proxymity's associated terms and conditions. It is important that you read these carefully as you will be bound by them and they will govern the electronic appointment of your proxy.
International Limited does not make available special procedures in CREST for any particular message. Normal system timings and limitations will, therefore, apply in relation to the input of CREST proxy instructions and the appropriate CREST message must be properly, authenticated in accordance with Euroclear's specifications and must contain the information required for such instructions and described in the CREST Manual (available via euroclear.com CREST). It is the responsibility of the CREST member concerned to take (or, if the CREST member is a CREST personal member, or sponsored member, or has appointed a voting service provider, to procure that his CREST sponsor or voting service provider(s) take(s) such action as shall be necessary to ensure that a message is transmitted by means of the CREST system by any particular time. In this connection, CREST members and, where applicable, their CREST sponsors or voting system providers are referred, in particular, to those sections of the CREST manual concerning practical limitations of the CREST system and timings.
(xi) Any person to whom this Notice is sent who is a person nominated under section 146 of the 2006 Act to enjoy information rights (a "Nominated Person") may have a right, under an agreement between him and the member by whom he was nominated, to be appointed (or to have someone else appointed) as a proxy for the AGM. If a Nominated Person has no such proxy appointment right or does not wish to exercise it, they may, under any such agreement, have a right to give instructions to the member as to the exercise of voting rights. The statement of the rights of members in relation to the appointment of proxies in paragraph (iv) above does not apply to Nominated Persons. The rights described in these paragraphs can only be exercised by members of the Company.
(xii) As at 4 April 2024 (being the last practicable date prior to the publication of this Notice) the Company's issued share capital consists of 341,785,245 ordinary shares, with 1,004,363 ordinary shares held in treasury. Therefore, the total voting rights in the Company as at 4 April 2024 are 340,780,882, carrying one vote each on a poll.
(xiv) Under section 527 of the 2006 Act, members meeting the relevant threshold requirements set out in that section may require the Company to publish on a website a statement setting out any matter relating to: (i) the audit of the Company's accounts (including the auditor's report and the conduct of the audit) that are to be laid before the Annual General Meeting; or (ii) any circumstance connected with an auditor of the Company ceasing to hold office since the last Annual General Meeting that the members propose to raise at the Annual General Meeting. The Company may not require the members requesting any such website publication to pay its expenses in complying with sections 527 or 528 of the 2006 Act.
Where the Company is required to place a statement on a website under section 527 or 528 (requirements asto website availability) of the 2006 Act, it must forward the statement to the Company's auditor not later than the time when it makes the statement available on the website. The business which may be dealt with at the Annual General Meeting includes any statement that the Company has been required under section 527 of the 2006 Act to publish on a website.
(xv) Under sections 338 and 338A of the 2006 Act, members meeting the threshold requirements in those sections have the right to require the Company: (a) to give, to members of the Company entitled to receive notice of the meeting, notice of a resolution which may properly be moved and is intended to be moved at the meeting; and/ or (b) to include in the business to be dealt with at the meeting any matter (other than a proposed resolution) which may be properly included in the business unless (i) (in the case of a resolution only) it would, if passed, be ineffective whether by reason of inconsistency with any enactment or the Company's constitution or otherwise, (ii) it is defamatory of any person, or (iii) it is frivolous or vexatious. Such a request may be in hard copy form or in electronic form, must identify the resolution of which notice is to be given or the matter to be included in the business, must be authorised by the person or persons making it, must be received by the Company not later than 4 April 2024, being the date six clear weeks before the meeting, and (in the case of a matter to be included on the business only) must be accompanied by a statement setting out the grounds for the request.
(xviii) A copy of this Notice and other information required to be published in accordance with section 311A of the 2006 Act in advance of the Annual General Meeting can be found at vistrygroup.co.uk.
(xxi) Data protection statement: your personal data includes all data provided by you, or on your behalf, which relates to you as a shareholder, including your name and contact details, the votes you cast and your Reference Number (attributed to you by the Company). The Company determines the purposes for which and the manner in which your personal data is to be processed. The Company and any third party to which it discloses the data (including the Company's Registrar) may process your personal data for the purposes of compiling and updating the Company's records, fulfilling its legal obligations and processing the shareholder rights you exercise.

Vistry Group PLC 11 Tower View, Kings Hill West Malling, Kent ME19 4UY
Company no. 00306718
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.